TRAX
First Tracks Biotherapeutics, Inc.
Last earnings -1.5% on 2026-05-14
$15.82▼ -16.74%
over 1Y
L $15.32Yahoo FinanceH $25.40
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W-13.6%
1M-2.0%
3M-16.7%
YTD-16.7%
1Y-16.7%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy
Mixed signals in the latest filings.
First Tracks Biotherapeutics, Inc. shows limited reported revenue.
Sources: SEC EDGAR (CIK 0002091349, latest 10-Q filed 2026-05-14) · as of 6/26/2026, 8:48:04 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.